Status:
COMPLETED
PooR Embryo Yield Cleavage Stage Versus blaStocyst Embryo Transfer (PILOT STUDY)
Lead Sponsor:
Beth Israel Deaconess Medical Center
Collaborating Sponsors:
Boston IVF
Conditions:
Infertility
Eligibility:
FEMALE
18-44 years
Phase:
NA
Brief Summary
The purpose of this small-scale pilot study (10 patients) is to test the study protocol for an RCT comparing IVF outcomes between day 3 and day 5 embryo transfer in patients with five or fewer embryos...
Detailed Description
Embryos created with assisted reproductive technology (ART, e.g. in vitro fertilization (IVF)) are commonly transferred into a woman's uterus at either the cleavage stage (day 3 after egg retrieval) o...
Eligibility Criteria
Inclusion
- First autologous IVF cycle
- Written, informed consent
Exclusion
- Planned gestational carrier
- Planned donor egg
- Morbid obesity: BMI \>40
- History of recurrent pregnancy loss (≥2 spontaneous abortions)
- Presence of uterine factor infertility
- Treatment plan includes embryos cultured 'out of protocol'
- Planned preimplantation genetic testing
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2022
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03764865
Start Date
March 1 2021
End Date
February 28 2022
Last Update
November 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston IVF
Waltham, Massachusetts, United States, 02451